Biosimilars could improve access to biologic treatments and health care sustainability in Latin America, but their adoption ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...

I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...

Although financial incentives introduced by Japan's 2022 health policy did not result in a reduction in overall drug costs, ...

Early adopters of biosimilars have paved the way for broader acceptance by sharing real-world success strategies, overcoming initial resistance, and highlighting best practices for integration and ...

Number 5: In 2 randomized controlled trials of maintenance therapy for inflammatory bowel disease (IBD), the subcutaneous formulation of the infliximab biosimilar CT-P13 demonstrated superiority to ...

This webinar celebrating Global Biosimilars Week was hosted by The Center for Biosimilars® in partnership with the International Generics and Biosimilars Association. This webinar celebrating Global ...